Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara Moorhouse will join the Board of Medica as a Non-Executive Director on 1 July 2021. Medica is the market leader in the UK and Ireland for the provision of teleradiology services, providing outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound, and plain film (x-ray) images. Medica also offers diabetic retinopathy screening in Ireland.

Barbara Moorhouse will serve as the Senior Independent Director and Chair of the Audit Committee. As previously announced, Steve Whittern, Senior Independent Non-Executive Director and Chair of the Audit Committee, will stand down from the Board ahead of the Annual General Meeting on 16 June 2021.

Barbara has extensive business and management experience in the private, public, and regulated sectors. In the private sector, Barbara has held a series of strategic, commercial, and finance roles, including being Chief Finance Officer for two international listed IT companies – Kewill Systems plc and Scala Business Solutions NV, Group Finance Director at Morgan Sindall plc, and Regulatory Director at South West Water.

In the public sector, she has been Director General at the Ministry of Justice and the Department for Transport and Chief Operating Officer at Westminster City Council. Barbara has been a Trustee and Chair of the Audit Committee for Guy’s & St Thomas’ Charity and a Non-Executive Director of the NHS West Hampshire Clinical Commissioning Group. She is Non-Executive Director at Balfour Beatty plc, Non-Executive Director and Chair of the Audit Committee at Aptitude Software Group plc and Chair of the Rail Safety & Standards Board. Barbara is currently Non-Executive Director at Agility Trains (East) Ltd but is stepping down this month having been on the board since 2015.

Roy Davis, Chairman of Medica, said: “We are delighted to have someone of Barbara’s expertise and stature join the Board of Medica. Barbara is a seasoned Non-Executive Director and brings significant experience from both the private and public sectors. Coupled with her extensive background in the most senior of finance positions in large scale, highly complex, and fast-growing organizations, Barbara will further strengthen Medica’s Board. I very much look forward to working with her.”

Commenting on her appointment, Barbara Moorhouse added: “I am very pleased to be joining the Board of such an exciting and rapidly-growing company with a compelling strategy in place. I am looking forward to engaging with the Board and the management team and using my expertise to help implement this strategy.”

 

SourceMedica

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution